Squamous cell lung cancer is one such rare form of the lung cancer, which does not have any treatment aiming at genetic mutations. The cancer is also considered to the most dangerous cancer among breast, colorectal and prostate cancer, as it takes maximum lives in comparison to other types of cancers being mentioned above.

However, a ray of hope has been given by a group of researchers from different institutes, like the Cancer Genome Atlas (TCGA) Research Network, Harvard Medical School and Dana-Farber Cancer Institute.

Study researchers were of the view that they have found 11 new genetic mutations in 178 squamous cell lung tumors. The study, which has been published in the journal Nature, has also revealed that the study researchers have been able to notice variations in gene known as HLA-A.

The gene is responsible for giving strength to the body to fight against the development of irregular tissue. “To our knowledge, this is the first example of a tumor that has a genomic mechanism for evading an immune response”, said Matthew Meyerson, who is the co-author of the study and is a researcher at Dana-Farber Cancer Institute as well as in Harvard Medical School, which is in Boston.